Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Express Scripts
Johnson and Johnson
Medtronic
Harvard Business School
Merck
Colorcon
Cantor Fitzgerald
McKesson

Generated: November 14, 2018

DrugPatentWatch Database Preview

Dexcel Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for DEXCEL PHARMA, and when can generic versions of DEXCEL PHARMA drugs launch?

DEXCEL PHARMA has six approved drugs.

There are two US patents protecting DEXCEL PHARMA drugs.

Summary for Dexcel Pharma
US Patents:2
Tradenames:5
Ingredients:5
NDAs:6
Patent Litigation for Dexcel Pharma: See patent lawsuits for Dexcel Pharma

Drugs and US Patents for Dexcel Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dexcel Pharma LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 202167-001 Sep 4, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Dexcel Pharma PERIOCHIP chlorhexidine gluconate TABLET;DENTAL 020774-001 May 15, 1998 RX Yes Yes ➤ Sign Up ➤ Sign Up
Dexcel Pharma LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 202167-002 Sep 4, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Dexcel Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dexcel Pharma PERIOCHIP chlorhexidine gluconate TABLET;DENTAL 020774-001 May 15, 1998 5,002,769 ➤ Sign Up
Dexcel Pharma PERIOCHIP chlorhexidine gluconate TABLET;DENTAL 020774-001 May 15, 1998 5,023,082 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Paragraph IV (Patent) Challenges for DEXCEL PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03

Supplementary Protection Certificates for Dexcel Pharma Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB01/006 United Kingdom ➤ Sign Up PRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727
11/016 Ireland ➤ Sign Up PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE MODIFIED-RELEASE TABLETS; NAT REGISTRATION NO/DATE: PA0970/060/001 20101221; FIRST REGISTRATION NO/DATE: PL17901/0263-0001 20101105
00C/032 Belgium ➤ Sign Up PRODUCT NAME: LEVETIRACETAM; NAT. REGISTRATION NO/DATE: EU/1/00/146/001 20000929; FIRST REGISTRATION: CH 55297 20000329
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Covington
Baxter
Cerilliant
Fish and Richardson
US Department of Justice
Johnson and Johnson
Merck
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.